000 01176 a2200313 4500
005 20250516235527.0
264 0 _c20150804
008 201508s 0 0 eng d
022 _a1873-281X
024 7 _a10.1016/j.tube.2014.09.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDutta, Noton K
245 0 0 _aThioridazine for treatment of tuberculosis: promises and pitfalls.
_h[electronic resource]
260 _bTuberculosis (Edinburgh, Scotland)
_cDec 2014
300 _a708-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Comment
650 0 4 _aAnimals
650 0 4 _aAntitubercular Agents
_xpharmacology
650 0 4 _aFemale
650 0 4 _aIsoniazid
_xpharmacology
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aPyrazinamide
_xpharmacology
650 0 4 _aRifampin
_xpharmacology
650 0 4 _aThioridazine
_xpharmacology
650 0 4 _aTuberculosis
_xdrug therapy
700 1 _aKarakousis, Petros C
773 0 _tTuberculosis (Edinburgh, Scotland)
_gvol. 94
_gno. 6
_gp. 708-11
856 4 0 _uhttps://doi.org/10.1016/j.tube.2014.09.001
_zAvailable from publisher's website
999 _c24258256
_d24258256